STROMECTOL

This brand name is authorized in United States. It is also authorized in Australia, Canada, Estonia, France, Japan, Malta, Mexico, Netherlands, New Zealand, Singapore.

Active ingredients

The drug STROMECTOL contains one active pharmaceutical ingredient (API):

1	Ivermectin UNII 8883YP2R6D - IVERMECTIN
	Ivermectin is a member of the avermectin class and has high affinity with glutamate-gated chloride channels present in invertebrate nerve and muscle cells. Its binding to these channels promotes an increase in membrane permeability to chloride ions, leading to hyperpolarization of the neural or muscle cell. This results in neuromuscular paralysis and may lead to the death of certain parasites.
	Read more about Ivermectin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
STROMECTOL Tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CF01	Ivermectin	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CF Avermectines
Discover more medicines within P02CF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2868Y, 8359Y
CA	Health Products and Food Branch	02480557
EE	Ravimiamet	1725331, 1782413
FR	Base de données publique des médicaments	61350360
JP	医薬品医療機器総合機構	6429008F1020
MT	Medicines Authority	AA565/92601
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	116M88
NL	Z-Index G-Standaard, PRK	69515
NZ	Medicines and Medical Devices Safety Authority	11299
SG	Health Sciences Authority	11897P
US	FDA, National Drug Code	0006-0032